Clinical Development Statistical Strategy
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.
We translate the protocol into statistical instructions clear enough to programme, review and interpret study results. Work can cover an initial document or justified, traceable updates.
This service authors the document. Risk Review evaluates an existing draft and prioritises findings; the two can be sequenced with defined reviewers and responsibilities.
Statistical consulting for clinical development: objectives, endpoints, populations, design options and evidence-generation strategy.
Statistical study design, sample size and power analysis for biomedical research, with documented scenarios, simulation, sampling and randomisation planning.
Data and assumption assessment for trial feasibility: eligibility, populations, follow-up and enrolment scenarios subject to validation.
Describe the objective, study stage and deadline. We will confirm fit, deliverables, timing and a quote based on complexity and data quality.
Do not email patient, clinical or confidential study data. Access and the working environment are agreed before materials are shared.
Discuss your project